Your browser doesn't support javascript.
loading
Advances in Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia--Review / 中国实验血液学杂志
Journal of Experimental Hematology ; (6): 1334-1338, 2019.
Article in Zh | WPRIM | ID: wpr-775718
Responsible library: WPRO
ABSTRACT
Abstract  At present, allogeneic hematopoietic stem cell transplantation is still the only way to cure chronic myelogenous leukemia. With the advances of HLA matching technology, application of tyrosine kinase inhibitors before and after transplantation, improvement of postoperative immune status and fusion gene monitoring, and the control of postoperative complications, especially graft-versus-host disease etc. allogeneic hematopoietic stem cell transplantation is displaying better efficacy in the treatment of chronic myelogenous leukemia, and the quality of life of patients has also been significantly improved. This article reviews the recent research advances on the allogeneic hematopoietic stem cell transplantation and related support technologies for treatment of chronic myeloid leukemia.
Subject(s)
Full text: 1 Index: WPRIM Main subject: Quality of Life / Transplantation, Homologous / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Limits: Humans Language: Zh Journal: Journal of Experimental Hematology Year: 2019 Type: Article
Full text: 1 Index: WPRIM Main subject: Quality of Life / Transplantation, Homologous / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Limits: Humans Language: Zh Journal: Journal of Experimental Hematology Year: 2019 Type: Article